Cubist Systematic Strategies, LLC Foghorn Therapeutics Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.44 - $9.46 $7,616 - $13,244
1,400 New
1,400 $8,000
Q2 2022

Aug 15, 2022
SELL
$8.48 - $16.84 $75,845 - $150,616
-8,944 Reduced 97.72%
209 $3,000
Q1 2022

May 16, 2022
SELL
$8.87 - $22.1 $108,063 - $269,244
-12,183 Reduced 57.1%
9,153 $139,000
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $230,215 - $487,954
21,336 New
21,336 $488,000

Others Institutions Holding FHTX

# of Institutions
72
Shares Held
32.7M
Call Options Held
6K
Put Options Held
1.8K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email